• Responses to COVID-19 vaccination vary after treatment for lymphoid malignancies

    11 days ago - By Healio

    Patients with lymphoid malignancies who received anti-CD20 therapy within the previous year did not demonstrate antibody responses to the messenger RNA COVID-19 vaccines, according to study results published in Blood Advances.
    “It has been observed that patients with lymphoid malignancies are at increased risk for COVID-19 and are at high risk for poor outcomes,” Jennifer L. Crombie, MD, oncologist and instructor in medicine at Dana-Farber Cancer Institute, told Healio. “Although vaccines have been shown to be effective in preventing or decreasing the severity of COVID-19,
    Read more ...

     

  • Study finds relatively low rate of COVID-19 infection following full vaccination in North Carolina

    Study finds relatively low rate of COVID-19 infection following full vaccination in North Carolina

    11 days ago - By News Medical

    A recent study seeks to investigate the characteristics of individuals with breakthrough infections post-vaccination in North Carolina, USA.
    Read more ...